In Kap Ko

In Kap Ko

Auto-generated profile, based on publicly available information

In Kap Ko

Wake Forest School of Medicine, Winston-Salem, NC

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JKJi Hyun Kim
Ji Hyun Kim
IKIckhee Kim
Ickhee Kim
YSYoung-Joon Seol
Young-Joon Seol
IKIn Kap Ko
In Kap Ko
JYJames J. Yoo
James J. Yoo
SLSang Jin Lee
Sang Jin Lee
A bioengineered skeletal muscle construct that mimics structural and functional characteristics of native skeletal muscle is a promising therapeutic option to treat extensive muscle defect injuries. We previously showed that bioprinted human skeletal muscle constructs were able to form multi-layered bundles with aligned myofibers. In this study, we investigate the effects of neural cell integration into the bioprinted skeletal muscle construct to accelerate functional muscle regeneration in vivo. Neural input into this bioprinted skeletal muscle construct shows the improvement of myofiber formation, long-term survival, and neuromuscular junction formation in vitro. More importantly, the bioprinted constructs with neural cell integration facilitate rapid innervation and mature into organized muscle tissue that restores normal muscle weight and function in a rodent model of muscle defect injury. These results suggest that the 3D bioprinted human neural-skeletal muscle constructs can be rapidly integrated with the host neural network, resulting in accelerated muscle function restoration.

30 June 2019 in Vascular Specialist International
Verified
Journal Article
Open access
SMSangil Min
Sangil Min
IKIn Kap Ko
In Kap Ko
JYJames Yoo
James Yoo
Engineering three-dimensional (3D) implantable tissue constructs is a promising strategy for replacing damaged or diseased tissues and organs with functional replacements. However, the efficient vascularization of new 3D organs is a major scientific and technical challenge since large tissue constructs or organs require a constant blood supply to survive in vivo. Current approaches to solving this problem generally fall into the following three major categories: (a) cell-based, (b) angiogenic factor-based, and (c) scaffold-based. In this review, we summarize state-of-the-art technologies that are used to develop complex, stable, and functional vasculature for engineered 3D tissue constructs and organs; additionally, we have suggested directions for future research.

30 May 2019 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
HYHyung Eun Yim
Hyung Eun Yim
DKDoo Sang Kim
Doo Sang Kim
HCHyun Chul Chung
Hyun Chul Chung
BSBrian Shing
Brian Shing
KMKyung Hyun Moon
Kyung Hyun Moon
JYJames Yoo
James Yoo
Renal disease is a worldwide health issue. Besides transplantation, current therapies revolve around dialysis, which only delays disease progression but cannot replace other renal functions, such as synthesizing erythropoietin. To address these limitations, cell‐based approaches have been proposed to restore damaged kidneys as an alternative to current therapies. Recent studies have shown that stem cell‐derived secretomes can enhance tissue regeneration. However, many growth factors undergo rapid degradation when they are injected into the body in a soluble form. Efficient delivery and controlled release of secreting factors at the sites of injury would improve the efficacy in tissue regeneration. Herein, we developed a gel‐based delivery system for controlled delivery of trophic factors in the conditioned medium (CM) secreted from human placental stem cells (HPSCs) and evaluated the effect of trophic factors on renal regeneration. CM treatment significantly enhanced cell proliferation and survival in vitro. Platelet‐rich plasma (PRP) was used as a delivery vehicle for CM. Analysis of the release kinetics demonstrated that CM delivery through the PRP gel resulted in a controlled release of the factors both in vitro and in vivo. In an acute kidney injury model in rats, functional and structural analysis showed that CM delivery using the PRP gel system into the injured kidney minimized renal tissue damage, leading to a more rapid functional recovery when compared with saline, CM, or vehicle only injection groups. These results suggest that controlled delivery of HPSC‐derived trophic factors may provide efficient repair of renal tissue injury. Stem Cells Translational Medicine 2019

3 May 2019 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
IKIn Kap Ko
In Kap Ko
EYEun Sang Yoo
Eun Sang Yoo
SPSang Mi Park
Sang Mi Park
BLBu‐Kyu Lee
Bu‐Kyu Lee
JKJi Hyun Kim
Ji Hyun Kim
AAAnthony Atala
Anthony Atala
Treatment of extensive muscle loss due to traumatic injury, congenital defects, or tumor ablations is clinically challenging. The current treatment standard is grafting of autologous muscle flaps, however significant donor site morbidity and graft tissue availability remain a problem. Alternatively, muscle fiber therapy has been attempted to treat muscle injury by transplanting single fibers into the defect site. However, irregularly organized long fibers resulted in low survivability due to delay in vascular and neural integration, thus limiting the therapeutic efficacy. Therefore, no effective method is available to permanently restore extensive muscle injuries. To address the current limitations, we developed a novel method that produces uniformly sized native muscle fiber fragments (MFFs) for muscle transplantation. We hypothesized that fragmentation of muscle fibers into small and uniformly sized fragments would allow for rapid reassembly and efficient engraftment within the defect site, resulting in accelerated recovery of muscle function. Our results demonstrate that the processed MFFs have a dimension of approximately 100 μm and contain living muscle cells on extracellular matrices (ECM). In preclinical animal studies using volumetric defect and urinary incontinence models, histological and functional analyses confirmed that the transplanted MFFs into the injury sites were able to effectively integrate with host muscle tissue, vascular, and neural systems, which resulted in significant improvement of muscle function and mass. These results indicate that the MFF technology platform is a promising therapeutic option for the restoration of muscle function, and can be applied to various muscle defect and injury cases.

1 September 2014 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
JJJohn R. Jackson
John R. Jackson
IKIn Kap Ko
In Kap Ko
SLSang Jin Lee
Sang Jin Lee
Anthony AtalaAnthony Atala
Anthony Atala
JYJames Yoo
James Yoo

1 October 2016 in Journal of the American College of Surgeons
Verified
Journal Article
Closed access
PDF file
JKJi Hyun Kim
Ji Hyun Kim
YSYoung-Joon Seol
Young-Joon Seol
IKIn Kap Ko
In Kap Ko
HKHyun-Wook Kang
Hyun-Wook Kang
JJJohn Jackson
John Jackson
Anthony AtalaAnthony Atala
Anthony Atala